Company intelligence / Profile preview
SSP
Narita, Chiba, Japanssp.navy.mil ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SSP is a leading Japanese OTC pharmaceutical company with top market share in antipyretic analgesics and oral rhinitis drugs. It pioneered the introduction of ibuprofen and L-cysteine as OTC drugs in Japan and developed proprietary fast-action formulations for headache relief and sleep-improving medications using antihistamines[1].
- Therapeutic areas
- DermatologyImmunologyNeurology
- Modalities
- Small moleculeVitamin-based products
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Parent companies include Boehringer Ingelheim and later Sanofi/Opella/CD&R.[7]
Beyond the preview
Go deeper on SSP.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SSP.